Tilray® Exports Medical Cannabis to South Africa
Tilray continues global expansion with medical cannabis products now available on five continents
First-ever export of plant-derived cannabinoid product to the continent of Africa.
NANAIMO, British Columbia – Tilray, a global pioneer in cannabis cultivation, processing and distribution, today announced that it has successfully exported medical cannabis products to South Africa for nationwide distribution to qualified patients through pharmacies. Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has ever been legally exported to and made available for medical purposes in the country of South Africa and on the continent of Africa.
“With this announcement, Tilray products are now available in nine countries on five continents. This export is another strategic milestone as we aim to build the world’s leading medical cannabis brand,” said Brendan Kennedy, Tilray CEO. “We are encouraged by the evolving regulations pertaining to cannabis in South Africa and around the world and are pleased to make our pharmaceutical-grade products available to qualified patients in need in throughout the country.”
Tilray’s medical cannabis product in South Africa is a GMP-manufactured, full-spectrum oral solution featuring a balanced ratio of tetrahydrocannabinol (THC) and cannabidiol (CBD). The product is available to qualified patients under South Africa’s named patient program. Through that program, authorized practitioners can apply for permission to access and prescribe unregistered medicines, including the Tilray product, when intending to treat individual patients for specific conditions where certain registered medicines have failed. The product will then be distributed to patients through authorized distribution channels.In South Africa, Tilray is proud to partner with BGM Pharmaceuticals, a locally-owned biotechnology company with a focus on providing innovative medical solutions to improve patient health outcomes in Africa. BGM is a level 1 Broad Based Black Economic Empowerment (BBBEE) research-focused company.
If you are interested in legally obtaining Tilray medical cannabis oil products in South Africa then you will need a completed Section 21 application form.
Please see the Section 21 application form here.
You will need to take it to your doctor to complete it and then submit it to the MCC/SAHPRA for approval.
The approval process should take no longer than 48hrs providing all the information is completed accurately.
To stay updated on the latest news on medical Cannabis South Africa sign up for the newsletter here.